Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,375 | 1,430 | 11:37 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Sequana Medical NV: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024 | 214 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET
Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024
Publication of Annual Report... ► Artikel lesen | |
Di | Sequana Medical NV: Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023 | 252 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET
Publication of Annual Report 2023
Ghent, Belgium - 23 April 2024
- Sequana Medical NV (Euronext Brussels: SEQUA) (the... ► Artikel lesen | |
11.04. | Sequana Medical NV: Transparency Notifications from Shareholders | 200 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION
11 April 2024, 06:00 pm CEST
Ghent, Belgium - 11 April 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
08.04. | Sequana Medical NV: Transparency Notifications from Shareholders | 362 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION
8 April 2024, 06:30 pm CEST
Ghent, Belgium - 8 April 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a... ► Artikel lesen | |
03.04. | Sequana Medical NV: Transparency Notifications from Shareholders | 218 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST
Ghent, Belgium - 3 April 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical"), a pioneer... ► Artikel lesen | |
03.04. | Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure | 309 | GlobeNewswire (Europe) | Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance
Ghent, Belgium - 3 April 2024
- Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
28.03. | Sequana Medical GAAP EPS of -€1.22, revenue of €0.71M | 1 | Seeking Alpha | ||
28.03. | Sequana Medical NV: Sequana Medical announces 2023 Full Year Results and 2024 Outlook | 596 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION28 March 2024, 08:00 a.m. CET
alfapump® - PMA1 submitted to US FDA and accepted for substantive review, extensive feedback just received... ► Artikel lesen | |
26.03. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES | 267 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION26 March 2024, 07:00 a.m. CET
Ghent, Belgium, 26 March 2024 - Sequana Medical NV
(Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
25.03. | Sequana Medical NV: Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy | 221 | GlobeNewswire (Europe) | MOJAVE - US Phase 1/2a study of DSR 2.0 for treatment of heart failure
Previously reported strong data maintained after three-months follow-up:
Diuretic response remained nearly normalized... ► Artikel lesen | |
21.03. | XFRA 2SE: WIEDERAUFNAHME/RESUMPTION | 176 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
21.03. | Sequana Medical NV: SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT | 343 | GlobeNewswire (Europe) | THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED... ► Artikel lesen | |
20.03. | Sequana Medical NV: Sequana Medical Launches Equity Placement And Provides Trading Update | 460 | GlobeNewswire (Europe) | THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED... ► Artikel lesen | |
20.03. | XFRA 2SE: AUSSETZUNG/SUSPENSION | 146 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSEQUANA MEDICAL... ► Artikel lesen | |
28.02. | Sequana Medical NV: Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024 | 461 | GlobeNewswire (Europe) | Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6th 2024
Ghent, Belgium - 28 February 2024
- Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
08.02. | Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES EUR 3.0 MILLION CONVERTIBLE FINANCING FROM MAJOR SHAREHOLDERS AND AGREEMENT WITH LENDERS ON DEFERRAL OF DEBT SERVICE PAYMENTS | 355 | GlobeNewswire (Europe) | THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED... ► Artikel lesen | |
29.01. | Sequana Medical NV: Sequana Medical announces FDA acceptance for substantive review of the Premarket Approval application for alfapump® in recurrent or refractory ascites due to liver cirrhosis | 395 | GlobeNewswire (Europe) | PRESS RELEASE
Acceptance and filing review is a first step in the PMA review process
Indicates PMA application is sufficiently complete for in-depth review
Received in advance of anticipated... ► Artikel lesen | |
24.01. | Sequana Medical NV: Transparency Notifications from Shareholders | 311 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION
24 January 2024, 06:00 pm CET
Ghent, Belgium - 24 January 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen | |
23.01. | Sequana Medical NV: Sequana Medical announces DSMB approval to start randomized MOJAVE cohort - US Phase 1/2a study of DSR® 2.0 for treatment of heart failure | 306 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION23 January 2024, 07:00 am CET
DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohortData from non-randomized... ► Artikel lesen | |
15.01. | Sequana Medical NV: Transparency Notifications from Shareholders | 449 | GlobeNewswire (Europe) | PRESS RELEASEREGULATED INFORMATION
15 January 2024, 06:00 pm CET
Ghent, Belgium - 15 January 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana
Medical")... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 27,070 | -0,40 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,40 | +0,19 % | Dividendenbekanntmachungen (19.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0425 EUR ALM BRAND A/S DK0015250344 0,55 DKK 0,0737 EUR APA CORPORATION US03743Q1085 0... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,70 | +1,72 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
ECKERT & ZIEGLER | 36,880 | +2,33 % | Eckert & Ziegler gutes Q1 - reicht zumindest für Prognosebestätigung. Und Kursfeuerwerk. Eintagsfliege? | Eckert & Ziegler (ISIN: DE0005659700) - Anfang Januar noch beim Platow Brief als klarer KAUF eingestuft - liefert heute im Rahmen einer ad-hoc-Meldung einen vorläufigen Blick auf die Q1-Zahlen, die... ► Artikel lesen | |
DRAEGERWERK | 49,300 | +0,51 % | Drägerwerk: Aktie wankt nach Gewinneinbruch | Der Medizin- und Sicherheitstechnikkonzern Drägerwerk hat seine Ergebnisse zum ersten Quartal bekanntgegeben. Das Unternehmen litt unter einem Umsatz- und Ergebnisrückgang. Die Aktie taumelt.Für das... ► Artikel lesen | |
MEDTRONIC | 74,19 | +0,46 % | Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity | According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, IRELAND / ACCESSWIRE... ► Artikel lesen | |
GERRESHEIMER | 99,75 | +0,55 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
UNITEDHEALTH | 457,60 | -0,61 % | UnitedHealth Aktie: Effektive Krisenbewältigung | UnitedHealth Group hat kürzlich technische Probleme bei seiner Technologieeinheit Change Healthcare behoben, die die Verarbeitung von medizinischen Ansprüchen für einige Kunden behindert hatten. Nach... ► Artikel lesen | |
STRATEC | 42,900 | +6,85 % | Minimale Kursveränderung bei Stratec-Aktie (40,00 €) | Der Kurs der dem Anteilsschein von Stratec kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Wertpapier 40,00 Euro. Einen minimalen Wertverlust von 0,12 Prozent zeigt die Kurstafel für die... ► Artikel lesen | |
ESSILORLUXOTTICA | 201,90 | -0,20 % | Aktien Europa: Schwächer - Lage an den Börsen trübt sich ein | PARIS/LONDON (dpa-AFX) - Europas wichtigste Aktienmärkte haben am Freitag wieder nachgeben. "Zwei Ängste treiben die Anleger um: Die Angst vor einem Flächenbrand in Nahost und die Angst vor einer Zinserhöhung... ► Artikel lesen | |
ALCON | 73,19 | -0,53 % | Alcon Publishes Agenda for 2024 Annual General Meeting | Alcon welcomes its shareholders to its second in-person AGM In addition to the regular agenda items, shareholders to vote on the Report on Non-Financial Matters Proposed dividend... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,041 | -4,21 % | Mountain Valley MD Holdings Inc: Mountain Valley licenses Agrarius plant signalling tech | ||
INSULET | 150,00 | -1,99 % | Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect | ||
QUEST DIAGNOSTICS | 128,60 | +1,82 % | Quest Diagnostics Q1 Profit Decreases, but beats estimates | WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) reported earnings for first quarter that decreased from the same period last year but beat the Street estimates.The company's bottom line came... ► Artikel lesen | |
ROCKWELL MEDICAL | 1,446 | +2,70 % | Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 | WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis... ► Artikel lesen |